APO Research
Talk to an analyst

APO RESEARCH · REPORT

Canine Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Canine Vaccine Industry Research Report 2026

26 December 2025131 pages

Choose your research edition.

Industry ResearchCanine Vaccine Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Canine Vaccine Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Canine Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Canine Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Canine Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Canine Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Canine Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Canine Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Canine Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Canine Vaccine include Biogenesis Bago, Boehringer Ingelheim, Durvet, NeoTech, Virbac, Pfizer, Jilin Five-Star Animal Health, JINHE and Wuhan Keqian Biology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Canine Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Canine Vaccine Market by Company

Biogenesis Bago

Boehringer Ingelheim

Durvet

NeoTech

Virbac

Pfizer

Jilin Five-Star Animal Health

JINHE

Wuhan Keqian Biology

SINOVAC

Elanco

Merck Animal Health

RuiPu Bio-Technology

Zoetis

CAHIC

Canine Vaccine Segment by Type

Core Vaccines

Non-Core Vaccines

Canine Vaccine Segment by Application

Puppies

Adult Dogs

Canine Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canine Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Canine Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canine Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Canine Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Canine Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Canine Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Canine Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Canine Vaccine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Canine Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Canine Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Canine Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Canine Vaccine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Canine Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Canine Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Canine Vaccine, Product Type & Application Table 14. Global Canine Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Canine Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Biogenesis Bago Company Information Table 19. Biogenesis Bago Business Overview Table 20. Biogenesis Bago Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Biogenesis Bago Canine Vaccine Product Portfolio Table 22. Biogenesis Bago Recent Developments Table 23. Boehringer Ingelheim Company Information Table 24. Boehringer Ingelheim Business Overview Table 25. Boehringer Ingelheim Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Boehringer Ingelheim Canine Vaccine Product Portfolio Table 27. Boehringer Ingelheim Recent Developments Table 28. Durvet Company Information Table 29. Durvet Business Overview Table 30. Durvet Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Durvet Canine Vaccine Product Portfolio Table 32. Durvet Recent Developments Table 33. NeoTech Company Information Table 34. NeoTech Business Overview Table 35. NeoTech Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. NeoTech Canine Vaccine Product Portfolio Table 37. NeoTech Recent Developments Table 38. Virbac Company Information Table 39. Virbac Business Overview Table 40. Virbac Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Virbac Canine Vaccine Product Portfolio Table 42. Virbac Recent Developments Table 43. Pfizer Company Information Table 44. Pfizer Business Overview Table 45. Pfizer Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Pfizer Canine Vaccine Product Portfolio Table 47. Pfizer Recent Developments Table 48. Jilin Five-Star Animal Health Company Information Table 49. Jilin Five-Star Animal Health Business Overview Table 50. Jilin Five-Star Animal Health Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Jilin Five-Star Animal Health Canine Vaccine Product Portfolio Table 52. Jilin Five-Star Animal Health Recent Developments Table 53. JINHE Company Information Table 54. JINHE Business Overview Table 55. JINHE Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. JINHE Canine Vaccine Product Portfolio Table 57. JINHE Recent Developments Table 58. Wuhan Keqian Biology Company Information Table 59. Wuhan Keqian Biology Business Overview Table 60. Wuhan Keqian Biology Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Wuhan Keqian Biology Canine Vaccine Product Portfolio Table 62. Wuhan Keqian Biology Recent Developments Table 63. SINOVAC Company Information Table 64. SINOVAC Business Overview Table 65. SINOVAC Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. SINOVAC Canine Vaccine Product Portfolio Table 67. SINOVAC Recent Developments Table 68. Elanco Company Information Table 69. Elanco Business Overview Table 70. Elanco Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Elanco Canine Vaccine Product Portfolio Table 72. Elanco Recent Developments Table 73. Merck Animal Health Company Information Table 74. Merck Animal Health Business Overview Table 75. Merck Animal Health Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Merck Animal Health Canine Vaccine Product Portfolio Table 77. Merck Animal Health Recent Developments Table 78. RuiPu Bio-Technology Company Information Table 79. RuiPu Bio-Technology Business Overview Table 80. RuiPu Bio-Technology Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. RuiPu Bio-Technology Canine Vaccine Product Portfolio Table 82. RuiPu Bio-Technology Recent Developments Table 83. Zoetis Company Information Table 84. Zoetis Business Overview Table 85. Zoetis Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Zoetis Canine Vaccine Product Portfolio Table 87. Zoetis Recent Developments Table 88. CAHIC Company Information Table 89. CAHIC Business Overview Table 90. CAHIC Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. CAHIC Canine Vaccine Product Portfolio Table 92. CAHIC Recent Developments Table 93. Global Canine Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Canine Vaccine Sales by Region (2021-2026) & (K Units) Table 95. Global Canine Vaccine Sales Market Share by Region (2021-2026) Table 96. Global Canine Vaccine Sales by Region (2027-2032) & (K Units) Table 97. Global Canine Vaccine Sales Market Share by Region (2027-2032) Table 98. Global Canine Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Canine Vaccine Revenue Market Share by Region (2021-2026) Table 100. Global Canine Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Canine Vaccine Revenue Market Share by Region (2027-2032) Table 102. North America Canine Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 104. North America Canine Vaccine Sales by Country (2027-2032) & (K Units) Table 105. North America Canine Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Canine Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Canine Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 109. Europe Canine Vaccine Sales by Country (2027-2032) & (K Units) Table 110. Europe Canine Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Canine Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Canine Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 114. Asia Pacific Canine Vaccine Sales by Country (2027-2032) & (K Units) Table 115. Asia Pacific Canine Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Canine Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Canine Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 119. South America Canine Vaccine Sales by Country (2027-2032) & (K Units) Table 120. South America Canine Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Canine Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Canine Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Canine Vaccine Sales by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Canine Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Canine Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Canine Vaccine Sales by Type (2021-2026) & (K Units) Table 128. Global Canine Vaccine Sales by Type (2027-2032) & (K Units) Table 129. Global Canine Vaccine Sales Market Share by Type (2021-2026) Table 130. Global Canine Vaccine Sales Market Share by Type (2027-2032) Table 131. Global Canine Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Canine Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Canine Vaccine Revenue Market Share by Type (2021-2026) Table 134. Global Canine Vaccine Revenue Market Share by Type (2027-2032) Table 135. Global Canine Vaccine Price by Type (2021-2026) & (US$/Unit) Table 136. Global Canine Vaccine Price by Type (2027-2032) & (US$/Unit) Table 137. Global Canine Vaccine Sales by Application (2021-2026) & (K Units) Table 138. Global Canine Vaccine Sales by Application (2027-2032) & (K Units) Table 139. Global Canine Vaccine Sales Market Share by Application (2021-2026) Table 140. Global Canine Vaccine Sales Market Share by Application (2027-2032) Table 141. Global Canine Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Canine Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Canine Vaccine Revenue Market Share by Application (2021-2026) Table 144. Global Canine Vaccine Revenue Market Share by Application (2027-2032) Table 145. Global Canine Vaccine Price by Application (2021-2026) & (US$/Unit) Table 146. Global Canine Vaccine Price by Application (2027-2032) & (US$/Unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Canine Vaccine Distributors List Table 150. Canine Vaccine Customers List Table 151. Canine Vaccine Industry Trends Table 152. Canine Vaccine Industry Drivers Table 153. Canine Vaccine Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Canine Vaccine Product Image Figure 5. Global Canine Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Canine Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Canine Vaccine Sales (2021-2032) & (K Units) Figure 8. Global Canine Vaccine Average Price (US$/Unit) & (2021-2032) Figure 9. Core Vaccines Product Image Figure 10. Non-Core Vaccines Product Image Figure 11. Puppies Product Image Figure 12. Adult Dogs Product Image Figure 13. Global Canine Vaccine Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Canine Vaccine, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Canine Vaccine Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Canine Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Canine Vaccine Sales by Region in 2025 Figure 19. Global Canine Vaccine Revenue by Region in 2025 Figure 20. North America Canine Vaccine Market Size by Country in 2025 Figure 21. North America Canine Vaccine Sales Market Share by Country (2021-2032) Figure 22. North America Canine Vaccine Revenue Market Share by Country (2021-2032) Figure 23. United States Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Canine Vaccine Market Size by Country in 2025 Figure 27. Europe Canine Vaccine Sales Market Share by Country (2021-2032) Figure 28. Europe Canine Vaccine Revenue Market Share by Country (2021-2032) Figure 29. Germany Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Canine Vaccine Market Size by Country in 2025 Figure 40. Asia Pacific Canine Vaccine Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Canine Vaccine Revenue Market Share by Country (2021-2032) Figure 42. China Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Canine Vaccine Market Size by Country in 2025 Figure 51. South America Canine Vaccine Sales Market Share by Country (2021-2032) Figure 52. South America Canine Vaccine Revenue Market Share by Country (2021-2032) Figure 53. Brazil Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Canine Vaccine Market Size by Country in 2025 Figure 57. Middle East and Africa Canine Vaccine Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Canine Vaccine Revenue Market Share by Country (2021-2032) Figure 59. Egypt Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Canine Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Canine Vaccine Sales Market Share by Type (2021-2032) Figure 65. Global Canine Vaccine Revenue Market Share by Type (2021-2032) Figure 66. Global Canine Vaccine Price (US$/Unit) by Type (2021-2032) Figure 67. Global Canine Vaccine Sales Market Share by Application (2021-2032) Figure 68. Global Canine Vaccine Revenue Market Share by Application (2021-2032) Figure 69. Global Canine Vaccine Price (US$/Unit) by Application (2021-2032) Figure 70. Canine Vaccine Value Chain Figure 71. Canine Vaccine Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Canine Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Core Vaccines
  • Non-Core Vaccines
Applications
  • Puppies
  • Adult Dogs
Companies covered
  • Biogenesis Bago
  • Boehringer Ingelheim
  • Durvet
  • NeoTech
  • Virbac
  • Pfizer
  • Jilin Five-Star Animal Health
  • JINHE
  • Wuhan Keqian Biology
  • SINOVAC
  • Elanco
  • Merck Animal Health
  • RuiPu Bio-Technology
  • Zoetis
  • CAHIC

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Canine Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Canine Vaccine Sales (2021-2032)
  5. 2.2.3 Global Canine Vaccine Market Average Price (2021-2032)
  6. 2.3 Canine Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Core Vaccines
  9. 2.3.3 Non-Core Vaccines
  10. 2.4 Canine Vaccine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Puppies
  13. 2.4.3 Adult Dogs
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Canine Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Canine Vaccine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Canine Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Canine Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Canine Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Canine Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Canine Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Canine Vaccine, Established Date
  9. 3.9 Global Canine Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Biogenesis Bago
  2. 4.1.1 Biogenesis Bago Company Information
  3. 4.1.2 Biogenesis Bago Business Overview
  4. 4.1.3 Biogenesis Bago Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Biogenesis Bago Canine Vaccine Product Portfolio
  6. 4.1.5 Biogenesis Bago Recent Developments
  7. 4.2 Boehringer Ingelheim
  8. 4.2.1 Boehringer Ingelheim Company Information
  9. 4.2.2 Boehringer Ingelheim Business Overview
  10. 4.2.3 Boehringer Ingelheim Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Boehringer Ingelheim Canine Vaccine Product Portfolio
  12. 4.2.5 Boehringer Ingelheim Recent Developments
  13. 4.3 Durvet
  14. 4.3.1 Durvet Company Information
  15. 4.3.2 Durvet Business Overview
  16. 4.3.3 Durvet Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Durvet Canine Vaccine Product Portfolio
  18. 4.3.5 Durvet Recent Developments
  19. 4.4 NeoTech
  20. 4.4.1 NeoTech Company Information
  21. 4.4.2 NeoTech Business Overview
  22. 4.4.3 NeoTech Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 NeoTech Canine Vaccine Product Portfolio
  24. 4.4.5 NeoTech Recent Developments
  25. 4.5 Virbac
  26. 4.5.1 Virbac Company Information
  27. 4.5.2 Virbac Business Overview
  28. 4.5.3 Virbac Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Virbac Canine Vaccine Product Portfolio
  30. 4.5.5 Virbac Recent Developments
  31. 4.6 Pfizer
  32. 4.6.1 Pfizer Company Information
  33. 4.6.2 Pfizer Business Overview
  34. 4.6.3 Pfizer Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Pfizer Canine Vaccine Product Portfolio
  36. 4.6.5 Pfizer Recent Developments
  37. 4.7 Jilin Five-Star Animal Health
  38. 4.7.1 Jilin Five-Star Animal Health Company Information
  39. 4.7.2 Jilin Five-Star Animal Health Business Overview
  40. 4.7.3 Jilin Five-Star Animal Health Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Jilin Five-Star Animal Health Canine Vaccine Product Portfolio
  42. 4.7.5 Jilin Five-Star Animal Health Recent Developments
  43. 4.8 JINHE
  44. 4.8.1 JINHE Company Information
  45. 4.8.2 JINHE Business Overview
  46. 4.8.3 JINHE Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 JINHE Canine Vaccine Product Portfolio
  48. 4.8.5 JINHE Recent Developments
  49. 4.9 Wuhan Keqian Biology
  50. 4.9.1 Wuhan Keqian Biology Company Information
  51. 4.9.2 Wuhan Keqian Biology Business Overview
  52. 4.9.3 Wuhan Keqian Biology Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Wuhan Keqian Biology Canine Vaccine Product Portfolio
  54. 4.9.5 Wuhan Keqian Biology Recent Developments
  55. 4.10 SINOVAC
  56. 4.10.1 SINOVAC Company Information
  57. 4.10.2 SINOVAC Business Overview
  58. 4.10.3 SINOVAC Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 SINOVAC Canine Vaccine Product Portfolio
  60. 4.10.5 SINOVAC Recent Developments
  61. 4.11 Elanco
  62. 4.11.1 Elanco Company Information
  63. 4.11.2 Elanco Business Overview
  64. 4.11.3 Elanco Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Elanco Canine Vaccine Product Portfolio
  66. 4.11.5 Elanco Recent Developments
  67. 4.12 Merck Animal Health
  68. 4.12.1 Merck Animal Health Company Information
  69. 4.12.2 Merck Animal Health Business Overview
  70. 4.12.3 Merck Animal Health Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Merck Animal Health Canine Vaccine Product Portfolio
  72. 4.12.5 Merck Animal Health Recent Developments
  73. 4.13 RuiPu Bio-Technology
  74. 4.13.1 RuiPu Bio-Technology Company Information
  75. 4.13.2 RuiPu Bio-Technology Business Overview
  76. 4.13.3 RuiPu Bio-Technology Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 RuiPu Bio-Technology Canine Vaccine Product Portfolio
  78. 4.13.5 RuiPu Bio-Technology Recent Developments
  79. 4.14 Zoetis
  80. 4.14.1 Zoetis Company Information
  81. 4.14.2 Zoetis Business Overview
  82. 4.14.3 Zoetis Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Zoetis Canine Vaccine Product Portfolio
  84. 4.14.5 Zoetis Recent Developments
  85. 4.15 CAHIC
  86. 4.15.1 CAHIC Company Information
  87. 4.15.2 CAHIC Business Overview
  88. 4.15.3 CAHIC Canine Vaccine Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 CAHIC Canine Vaccine Product Portfolio
  90. 4.15.5 CAHIC Recent Developments
5 Global Canine Vaccine Market Scenario by Region
  1. 5.1 Global Canine Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Canine Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Canine Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Canine Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Canine Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Canine Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Canine Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Canine Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Canine Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Canine Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Canine Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Canine Vaccine Market Facts & Figures by Country
  16. 5.5.1 Europe Canine Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Canine Vaccine Sales by Country (2021-2032)
  18. 5.5.3 Europe Canine Vaccine Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Canine Vaccine Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Canine Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Canine Vaccine Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Canine Vaccine Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Canine Vaccine Market Facts & Figures by Country
  41. 5.7.1 South America Canine Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Canine Vaccine Sales by Country (2021-2032)
  43. 5.7.3 South America Canine Vaccine Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Canine Vaccine Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Canine Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Canine Vaccine Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Canine Vaccine Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Canine Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Canine Vaccine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Canine Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Canine Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Canine Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Canine Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Canine Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Canine Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Canine Vaccine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Canine Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Canine Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Canine Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Canine Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Canine Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Canine Vaccine Value Chain Analysis
  2. 8.1.1 Canine Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Canine Vaccine Production Mode & Process
  5. 8.2 Canine Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Canine Vaccine Distributors
  8. 8.2.3 Canine Vaccine Customers
9 Global Canine Vaccine Analyzing Market Dynamics
  1. 9.1 Canine Vaccine Industry Trends
  2. 9.2 Canine Vaccine Industry Drivers
  3. 9.3 Canine Vaccine Industry Opportunities and Challenges
  4. 9.4 Canine Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst